Advancing Care for AA Amyloidosis with Biomarker-Based Staging

被引：0
|
作者：
Lachmann, Helen J. [1 ,2 ]
机构：
[1] UCL, Natl Amyloidosis Ctr, London, England
[2] Royal Free Hosp London NHS Fdn Trust, London, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 06期
关键词：
malfolding proteins; progression of renal failure;
D O I：
10.1681/ASN.0000000000000380
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 678
页数：3
相关论文
共 50 条
  • [1] Biomarker-based staging of Alzheimer disease: rationale and clinical applications
    Therriault, Joseph
    Schindler, Suzanne E.
    Salvado, Gemma
    Pascoal, Tharick A.
    Benedet, Andrea Lessa
    Ashton, Nicholas J.
    Karikari, Thomas K.
    Apostolova, Liana
    Murray, Melissa E.
    Verberk, Inge
    Vogel, Jacob W.
    La Joie, Renaud
    Gauthier, Serge
    Teunissen, Charlotte
    Rabinovici, Gil D.
    Zetterberg, Henrik
    Bateman, Randall J.
    Scheltens, Philip
    Blennow, Kaj
    Sperling, Reisa
    Hansson, Oskar
    Jack Jr, Clifford R.
    Rosa-Neto, Pedro
    [J]. NATURE REVIEWS NEUROLOGY, 2024, 20 (04) : 232 - 244
  • [2] Biomarker-based staging of Alzheimer disease: rationale and clinical applications
    Joseph Therriault
    Suzanne E. Schindler
    Gemma Salvadó
    Tharick A. Pascoal
    Andréa Lessa Benedet
    Nicholas J. Ashton
    Thomas K. Karikari
    Liana Apostolova
    Melissa E. Murray
    Inge Verberk
    Jacob W. Vogel
    Renaud La Joie
    Serge Gauthier
    Charlotte Teunissen
    Gil D. Rabinovici
    Henrik Zetterberg
    Randall J. Bateman
    Philip Scheltens
    Kaj Blennow
    Reisa Sperling
    Oskar Hansson
    Clifford R. Jack
    Pedro Rosa-Neto
    [J]. Nature Reviews Neurology, 2024, 20 : 232 - 244
  • [3] Development and Validation of Staging Systems for AA Amyloidosis
    Basset, Marco
    Schoenland, Stefan O.
    Obici, Laura
    Gunther, Janine
    Riva, Eloisa
    Dittrich, Tobias
    Milani, Paolo
    Ferretti, Virginia Valeria
    Pasquinucci, Ettore
    Foli, Andrea
    Kimmich, Christoph
    Nanci, Martina
    Bellofiore, Claudia
    Benigna, Francesca
    Beimler, Joerg
    Benvenuti, Pietro
    Fabris, Francesca
    Mussinelli, Roberta
    Nuvolone, Mario
    Klersy, Catherine
    Albertini, Riccardo
    Merlini, Giampaolo
    Hegenbart, Ute
    Palladini, Giovanni
    Blank, Norbert
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (06): : 782 - 794
  • [4] Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis
    Palladini, Giovanni
    Basset, Marco
    Milani, Paolo
    Varettoni, Marzia
    Mangiacavalli, Silvia
    Russo, Francesca
    Foli, Andrea
    Corso, Alessandro
    Merlini, Giampaolo
    [J]. BLOOD, 2017, 130
  • [5] BIOMARKER-BASED DRUG DEVELOPMENT IN NSCLC
    Jaenne, P. A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 11 - 11
  • [6] The pitfalls of biomarker-based classification schemes
    Illan-Gala, Ignacio
    Vilaplana, Eduard
    Pegueroles, Jordi
    Montal, Victor
    Alcolea, Daniel
    Blesa, Rafael
    Lleo, Alberto
    Fortea, Juan
    [J]. ALZHEIMERS & DEMENTIA, 2017, 13 (09) : 1072 - 1074
  • [7] BIOMARKER-BASED CANCER THERAPY PERSONALIZATION
    Yamada, T.
    Masuda, M.
    Honda, K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 54 - 54
  • [8] Biomarker-based dissection of neurodegenerative diseases
    Olsson, Bob
    Zetterberg, Henrik
    Hampel, Harald
    Blennow, Kaj
    [J]. PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 520 - 534
  • [9] Biomarker-based risk prediction in the community
    AbouEzzeddine, Omar F.
    McKie, Paul M.
    Scott, Christopher G.
    Rodeheffer, Richard J.
    Chen, Horng H.
    Felker, G. Michael
    Jaffe, Allan S.
    Burnett, John C.
    Redfield, Margaret M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (11) : 1342 - 1350
  • [10] TBI Rehabilomics Research: an Exemplar of a Biomarker-Based Approach to Precision Care for Populations with Disability
    Amy K. Wagner
    [J]. Current Neurology and Neuroscience Reports, 2017, 17
12345